Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 17 Prostatic Neoplasms 9 Breast Neoplasms 8 Fallopian Tube Neoplasms 7 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Ovarian 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡